Quick Answer
EXOZYMES INC. reported Stockholders Equity of $3.40 million for the year ending 2025.
- EXOZYMES INC. showed a decrease of -67.4% in Stockholders Equity from 2024 to 2025.
- This data is from EXOZYMES INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $1.19 million | Q2 2023: $1.07 million | Q3 2023: $607.1 thousand | Q1 2024: -$1.25 million | Q2 2024: -$2.26 million | Q3 2024: -$3.60 million | Q1 2025: $8.88 million | Q2 2025: $7.24 million | Q3 2025: $5.37 million.
- Over the full 4 years of available data (2022 to 2025), EXOZYMES INC.'s Stockholders Equity has grown by 147.5%.
- Historical annual values: Fiscal year 2025: $3.40 million | Fiscal year 2024: $10.42 million | Fiscal year 2023: -$384.3 thousand | Fiscal year 2022: $1.37 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: